Skip to main content
. 2020 Oct 12;8:590119. doi: 10.3389/fcell.2020.590119

FIGURE 2.

FIGURE 2

Cellular and molecular phenotypes revealed by brain organoid models of epilepsy and ASDs. The figure summarize how integration of brain organoids technology (forebrain assembloids, cortical organoids, whole brain organoids, and forebrain organoids) with multiple experimental approaches (including live imaging, CRISPR/Cas9 genome editing, scRNA-seq, and genome wide transcriptome analysis) allowed the understanding of various molecular mechanisms underlying epileptic and autism spectrum disorders (created with biorender.com).